Literature DB >> 30285222

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

D Planchard1, S Popat2, K Kerr3, S Novello4, E F Smit5, C Faivre-Finn6, T S Mok7, M Reck8, P E Van Schil9, M D Hellmann10, S Peters11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30285222     DOI： 10.1093/annonc/mdy275

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  427 in total

1.  Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.

Authors:  Laura Bonanno; Alberto Pavan; Alessandra Ferro; Lorenzo Calvetti; Stefano Frega; Giulia Pasello; Giuseppe Aprile; Valentina Guarneri; PierFranco Conte
Journal:  Oncologist       Date:  2020-07-07

Review 2.  Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.

Authors:  Alex Friedlaender; Giuseppe Luigi Banna; Lucio Buffoni; Alfredo Addeo
Journal:  Curr Oncol Rep       Date:  2019-11-25       Impact factor: 5.075

3.  Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey.

Authors:  Pinkie Chambers; Kenneth K C Man; Vivian W Y Lui; Sheila Mpima; Paola Nasuti; Martin D Forster; Ian C K Wong
Journal:  JCO Oncol Pract       Date:  2020-03-11

4.  Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus.

Authors:  D Isla; J de Castro; R García-Campelo; P Lianes; E Felip; P Garrido; L Paz-Ares; J M Trigo
Journal:  Clin Transl Oncol       Date:  2019-07-31       Impact factor: 3.405

5.  Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?

Authors:  Francesco Passiglia; Silvia Novello
Journal:  Ann Transl Med       Date:  2018-12

6.  Ethnic Disparities in Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer.

Authors:  Rustain L Morgan; Sana D Karam; Cathy J Bradley
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

7.  Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review.

Authors:  Stepan M Esagian; Georgia Ι Grigoriadou; Ilias P Nikas; Vasileios Boikou; Peter M Sadow; Jae-Kyung Won; Konstantinos P Economopoulos
Journal:  J Cancer Res Clin Oncol       Date:  2020-05-27       Impact factor: 4.553

8.  Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial.

Authors:  Hirotaka Miyashita; Christina Cruz; Cardinale Smith
Journal:  Support Care Cancer       Date:  2020-08-03       Impact factor: 3.603

Review 9.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

10.  Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.

Authors:  Marie-Julie Nokin; Elodie Darbo; Camille Travert; Benjamin Drogat; Aurélie Lacouture; Sonia San José; Nuria Cabrera; Béatrice Turcq; Valérie Prouzet-Mauleon; Mattia Falcone; Alberto Villanueva; Haiyun Wang; Michael Herfs; Miguel Mosteiro; Pasi A Jänne; Jean-Louis Pujol; Antonio Maraver; Mariano Barbacid; Ernest Nadal; David Santamaría; Chiara Ambrogio
Journal:  JCI Insight       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.